Our Story
About Us
Neumous advances the treatment of neurological disorders through a non-invasive focused ultrasound platform for BBB opening, targeted drug delivery, and neuromodulation.
Our technology enables new therapeutic approaches by enhancing the delivery of therapeutics to the brain and precisely modulating neural activity.
Mission
Delivering the Value of Life to Patients with Brain Diseases,
and the Value of Opportunity to the Healthcare Industry
Going beyond the laboratory, we bring the hope of life to patients suffering from brain diseases in clinical settings.
Furthermore, we provide global pharmaceutical and healthcare partners with new drivers for growth, creating meaningful value across the industry ecosystem.
Vision
Establishing a Foundation for Global Expansion
in Brain Disorder Therapeutics Alongside Global Partners
Based on our ultrasound-mediated BBB opening and treatment technology, we co-develop brain disease therapeutics with global pharmaceutical leaders and validate their clinical efficacy, laying a solid foundation for entering the international market.
Core Values
-
-
Align for Synergy
We come together centered around our shared system. We align our goals and efforts to channel everyone's energy efficiently and maximize execution impact.
-
-
Drive Action Items
We engage in conversations with clear purposes and conclusions. A dialogue is truly meaningful only when it moves beyond a simple exchange of opinions to derive concrete action items that lead to execution.
-
-
Grow Beyond Limits
We clearly recognize our strengths and limitations, using them as a foundation to expand our boundaries. While deepening our expertise, we boldly take on new roles, creating greater opportunities through accumulated experience and capabilities.